New device could provide an alternative to opioids and other highly addictive drugs
Two of the most common genetic changes that cause cells to become cancerous, which were previously thought to be separate and regulated by different cellular signals, are working in concert, according to new research from the University of Wisconsin–Madison.
Rice, MD Anderson study highlights potential of mitochondria-targeted chemotherapies
West Nile virus may no longer be a death sentence to crows.
By tracing the steps of liver regrowth, MIT engineers hope to harness the liver’s regenerative abilities to help treat chronic disease.
Scientists have demonstrated how some fast-growing bacteria can resist treatment with antibiotics, according to a study published today in eLife.
There’s no ‘magic set of pills to keep you healthy.’ Diet and exercise are key.
Paxlovid rebound patient did not show drug resistance or impaired immunity; UC San Diego study suggests insufficient drug exposure was most likely cause
Designing new drugs that can target specific diseases is a challenging but crucial task for preventing and treating human diseases.
Based on an antibody study, dried samples of easily self-collected saliva and of blood drawn from the fingertip could be useful for monitoring people’s immune responses to vaccination.
SPOKANE, Wash.—Experiencing higher rates of certain cancers than non-Hispanic whites, many Native Americans have to travel especially large distances to access radiation therapy, according to a study led by Washington State University researchers.
Vaccinating household chicken flocks can increase availability and consumption of eggs and meat, leading to better growth of young children in agriculture-dependent families in rural Kenya.
A collaboration between the Weizmann Institute in Israel and Harvard University developed a mathematical model to test the safety of a class of anti-viral drugs that accelerate the mutation rate of the virus, causing “death by mutagenesis.”
A study indicates that antibiotics, which kill bacteria, boost the abundance of gut fungal microbiota. The phenomenon can be a contributing factor in the long-term adverse effects of antibiotics, such as inflammatory bowel diseases.
Most antibiotics are double-edged swords. Besides killing the pathogen they are prescribed for, they also decimate beneficial bacteria and change the composition of the gut microbiome. As a result, patients become more prone to reinfection, and drug-resistant strains are more likely to emerge.
Key to possible HIV cure may lie in mechanisms behind how it replicates
Antiretroviral therapy has made HIV a manageable condition, but it does not eliminate the virus from the body—and most regimens are expensive and require a pill every day, for the rest of the patient’s life.
Minorities Have Fewer Exams, Higher Rates of Illness
Tumour DNA circulating in the bloodstream of patients with aggressive lymphoma has a previously unknown and even crucial role in the identification of effective therapies for this serious disease.
Using federated analysis on protected health data sets can lead scientists to a more nuanced understanding of heritable disease